DiscoverOptimum PerspectivesQ&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease
Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

Update: 2025-08-05
Share

Description

The latest episode of Optimum Perspectives Podcast has just dropped, featuring LoQus23 Therapeutics’ Chief Scientific Officer and founder Caroline Benn!


Listen as Caroline details the devastating effects of Huntington’s Disease on patients and families, her personal motivations for working in this therapeutic area, as well as LoQus23’s unique approach to battling the disease through their innovative small molecule approach.


Hosted on Acast. See acast.com/privacy for more information.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease